Eman Zedan

NPI: 1861929101
Total Payments
$576.02
2024 Payments
$252.85
Companies
9
Transactions
33
Medicare Patients
362
Medicare Billing
$24,973

Payment Breakdown by Category

Food & Beverage$576.02 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $576.02 33 100.0%

Top Paying Companies

Company Total Records Latest Year
Exact Sciences Corporation $251.25 13 $0 (2024)
Lilly USA, LLC $94.14 6 $0 (2024)
Merck Sharp & Dohme LLC $56.52 4 $0 (2022)
Phadia US Inc. $54.42 3 $0 (2024)
ABBVIE INC. $42.00 2 $0 (2023)
Novo Nordisk Inc $31.53 2 $0 (2022)
Amgen Inc. $16.83 1 $0 (2024)
Azurity Pharmaceuticals, Inc. $15.00 1 $0 (2023)
PFIZER INC. $14.33 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $252.85 14 Exact Sciences Corporation ($180.51)
2023 $138.06 7 Exact Sciences Corporation ($70.74)
2022 $103.44 7 Lilly USA, LLC ($43.02)
2021 $81.67 5 Merck Sharp & Dohme Corporation ($27.61)

All Payment Transactions

33 individual payment records from CMS Open Payments — Page 2 of 2

Date Company Product Nature Form Amount Type
05/09/2022 Lilly USA, LLC TRULICITY (Drug) Food and Beverage In-kind items and services $13.85 General
Category: Diabetes
02/22/2022 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $17.18 General
Category: Diabetes
02/02/2022 Merck Sharp & Dohme LLC STEGLATRO (Drug) Food and Beverage In-kind items and services $13.91 General
Category: ENDOCRINOLOGY
06/30/2021 Novo Nordisk Inc Ozempic (Drug), RYBELSUS Food and Beverage In-kind items and services $14.35 General
Category: Diabetes
05/11/2021 Lilly USA, LLC TRULICITY (Drug) Food and Beverage In-kind items and services $14.71 General
Category: Diabetes
03/24/2021 Merck Sharp & Dohme Corporation JANUVIA (Drug), STEGLATRO Food and Beverage In-kind items and services $13.88 General
Category: ENDOCRINOLOGY
02/03/2021 Merck Sharp & Dohme Corporation JANUVIA (Drug), STEGLATRO Food and Beverage In-kind items and services $13.73 General
Category: ENDOCRINOLOGY
01/26/2021 AbbVie Inc. UBRELVY (Drug) Food and Beverage In-kind items and services $25.00 General
Category: NEUROSCIENCE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 47 65 $21,675 $4,745
2022 4 94 140 $35,795 $9,615
2021 5 146 167 $14,776 $4,718
2020 3 75 98 $28,545 $5,895
Total Patients
362
Total Services
470
Medicare Billing
$24,973
Procedure Codes
14

All Medicare Procedures & Services

14 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 34 50 $18,000 $3,932 21.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 13 15 $3,675 $813.24 22.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 40 67 $24,120 $6,160 25.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 29 39 $9,555 $2,352 24.6%
87635 Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen Office 2022 13 18 $1,800 $843.10 46.8%
87880 Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) Office 2022 12 16 $320.00 $260.52 81.4%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 17 22 $7,920 $1,849 23.3%
0012A Adm sarscov2 100mcg/0.5ml2nd Office 2021 24 24 $1,140 $1,053 92.4%
0011A Adm sarscov2 100mcg/0.5ml1st Office 2021 41 41 $1,060 $1,013 95.5%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 17 19 $4,655 $802.32 17.2%
91301 Sarscov2 vac 100mcg/0.5ml im Office 2021 47 61 $0.61 $0.61 100.0%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 42 61 $14,945 $2,896 19.4%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2020 14 14 $5,320 $1,549 29.1%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 19 23 $8,280 $1,450 17.5%

About Eman Zedan

Eman Zedan is a Adult Health healthcare provider based in Jersey City, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2017. The National Provider Identifier (NPI) number assigned to this provider is 1861929101.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Eman Zedan has received a total of $576.02 in payments from pharmaceutical and medical device companies, with $252.85 received in 2024. These payments were reported across 33 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($576.02).

As a Medicare-enrolled provider, Zedan has provided services to 362 Medicare beneficiaries, totaling 470 services with total Medicare billing of $24,973. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.

Practice Information

  • Specialty Adult Health
  • Other Specialties Gerontology, Primary Care
  • Location Jersey City, NJ
  • Active Since 05/17/2017
  • Last Updated 05/17/2017
  • Taxonomy Code 363LA2200X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1861929101

Products in Payments

  • Cologuard Collection Kit (Device) $251.25
  • ImmunoCAP (Device) $54.42
  • MOUNJARO (Drug) $51.37
  • UBRELVY (Drug) $42.00
  • TRULICITY (Drug) $28.56
  • JANUVIA (Drug) $27.61
  • Rybelsus (Drug) $17.18
  • Otezla (Drug) $16.83
  • Adthyza (Drug) $15.00
  • BELSOMRA (Drug) $15.00
  • Ozempic (Drug) $14.35
  • PREVNAR 20 (Biological) $14.33
  • EMGALITY (Drug) $14.21
  • STEGLATRO (Drug) $13.91

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Adult Health Doctors in Jersey City